Affiliation:
1. Department of Biochemistry, School of Biomedical Sciences University of Otago Dunedin New Zealand
2. Department of Pediatrics Boston Children's Hospital Harvard Medical School Boston Boston Massachusetts USA
Abstract
AbstractA key signalling pathway required for clearance of viruses from host cells relies on the receptor protein, retinoic acid‐inducible gene I (RIG‐I). The activity of RIG‐I is tightly controlled, and once bound to viral dsRNA, addition of lysine 63‐linked ubiquitin chains activates signalling. Meanwhile, the addition of lysine 48‐linked ubiquitin chains to RIG‐I is required to terminate signalling when the infection has been resolved. Really interesting new gene (RING) finger protein 125 (RNF125) is the E3 ligase responsible for addition of the ubiquitin chains that terminate signalling, with disruption of its function associated with Tenorio syndrome. Here we describe a novel RNF125 gene variant in an individual with clinical symptoms including intellectual disability, macrocephaly and congenital heart disease, consistent with Tenorio syndrome. The newly identified Tenorio syndrome‐associated variant [(NM_017831.4):c.670G>C p.Glu224Gln] is the first to be found in the ubiquitin interaction motif (UIM) of RNF125. While the E3 ligase activity of this RNF125 variant is retained, it has an impaired ability to interact with lysine 63‐linked ubiquitin chains. The function of the UIM in RNF125 is uncertain; however, this study suggests that the UIM binds lysine 63‐linked ubiquitin chains, and that this interaction is required for the normal function of RNF125.
Funder
Health Research Council of New Zealand
Simons Foundation
Subject
Genetics (clinical),Genetics